,1009 atricsgarld Biochemistry, Brown Univ., Providence, RI
Regulation of glycemia r e q u i r e s t h e p r e c i s e cont r o l of glycogen metabolism. Regulation i n t r i n s i c t o the protein-glycogen complex can be s t u d i e d by " f l a s h a c t i v a t i o n " of glycogenolysis. I n t h i s procedure, t h e a d d i t i o n of Ca++ and
MgATP t o p u r i f i e d r a b b i t s k e l e t a l muscle glycogen p a r t i c l e s res u l t e d i n conversion of 80% of phosphorylase ( P ) t o t h e a c t i v e form i n 1 min, followed by r e t u r n t o b a s e l i n e (5%) by 2 min. Using 3 2~-A T P , phosphorylation of P, p-subunit of phosphorylase kinase (PK), glycogen synthase (GS) and an u n i d e n t i f i e d 32kDa p r o t e i n was detected by PAGE-SDS.
Activation of P and 3 2~ labeli n g were Ca++-dependent and temporally p a r a l l e l , a s were i n a c t iv a t i o n and dephosphorylation.
Unidentified p r o t e i n s a t 69kDa and 19kDa were labeled independently of Ca++ and were not dephosphory l a t e d . I n c o n t r a s t , h e p a t i c glycogen p a r t i c l e s could not be " f l a s h a c t i v a t e d " , even with attempts t o f u r t h e r optimize condit i o n s . Labeling showed no Ca++-dependent phosphorylation, but a d d i t i o n of CAMP-dependent p;otein kinase phosphorylated a-and p-subunits of PK ( a s well a s GS and t h e 32kDa p r o t e i n ) i n l i v e r , a s i t had i n s k e l e t a l muscle preparations.
Nonetheless, " f l a s h a c t i v a t i o n " of h e p a t i c glycogen p a r t i c l e s did not occur even upon a d d i t i o n of CAMP o r t h e p r o t e i n k i n a s e c a t a l y t i c s u b u n i t . W e conclude: 1 ) Only Ca++ and MgATP a r e needed t o t r i g g e r glycogenol y s i s i n muscle glycogen p a r t i c l e s ; 2) Additional unknown f a c t o r s a r e r e q u i r e d i n l i v e r glycogen p a r t i c l e s , even following CAMPdependent phosphorylation; 3 ) There a r e fundamental d i f f e r e n c e s i n t h e r e g u l a t i o n of l i v e r and muscle glycogen metabolism. The assessment o f f e t a l and maternal B-cell funct i o n by C-peptide measurement r e q u i r e s an understanding of i t s metabolism i n pregnancy. W e gave 1251-tyrosylated-C-peptide ( I-cP) t o 6 pregnant Rhesus monkeys by bolus followed by constant i n f u s i o n . This r e s u l t e d i n a s t e a d y s t a t e i n t h e mat e r n a l c i r c u l a t i o n o f immunoprecipitable cpm, a s measured using excess C-peptide antiserum. At t h e end o f t h e 2 o r 4 h r i n f u s i o n f e t u s e s were exsanguinated v i a t h e umbilical vein. I n t h e umbili c a l venous plasma (WP) 3-1356 o f t o t a l cpm were immunoprecipit a b l e . WP immunoprecipitable cpm r e p r e s e n t e d 1.4-5.8% of matern a l immunoprecipitable cpm a t d e l i v e r y . Medium p r e s s u r e g e l f i lt r a t i o n chromatography o f WP showed t h a t t h e immunoprecipitable cpm were due t o a fragment of I-CP approximately 25 amino a c i d s long. The predominant immunoprecipitable peak i n maternal plasma was i n t a c t I-CP; a peak corresponding t o t h e f e t a l immunoprecipit a b l e peak was a l s o p r e s e n t . Simultaneous maternal a r t e r i a l and u t e r i n e vein samples showed t h a t t h e degradation of I -C P occured a c r o s s t h e u t e r u s . Comparison t o s t u d i e s i n 3 post-partum animals i n d i c a t e d t h a t pregnancy i n c r e a s e d t h e r a t e of appearance o f I-CP metabolites.
F u r t h e r , when I-CP was incubated with trophob l a s t i c c e l l s i n c u l t u r e , degradation t o t h e f e t a l immunoreactive s p e c i e s was observed. W e conclude t h a t pregnancy a l t e r s maternal C-peptide metabolism, owing l a r g e l y t o p l a c e n t a l metabolism. Though p l a c e n t a l passage was i n s u f f i c i e n t t o a l t e r i n t e r p r e t a t i o n of f e t a l measurements, t h e p l a c e n t a may degrade f e t a l C-peptide.
HYPERINSULINISM: A REVERSIBLE CAUSE OF HYPER-TROPHIC CARDIOMYOPATHY. James P. Gutai, J . P e t e r H a r r i s , David J. Dabbs. East Carolina University 10 1 1 of Medicine, Depts. Ped. and Path., G r e e n v i l l e , N.C.
The r o l e of i n s u l i n i n c a r d i a c muscle growth has been c o n t r o v e r s i a l .
I n v i t r o s t u d i e s have had equivocal r e s u l t s but i n s u l i n has been implicated a s an e t i o l o g i c f a c t o r i n t h e hypertrophic cardiomyopathy seen i n t h e i n f a n t of a d i a b e t i c mother. W e have r e c e n t l y cared f o r an i n f a n t w i t h neonatal hypoglycemia secondary t o endogenous organic hyperinsulinism (blood glucose 22mgldl; i n s u l i n 92uUlml) t h a t was r e f r a c t o r y t o diazoxide, c h l o r o t h i a z i d e and g l u c o c o r t i c o i d s . Despite a 95% pancreatectomy on day 30 which showed i s l e t hypertrophylhyperplasia with o v e r a l l f e a t u r e s of endocrine c e l l d y s p l a s i a , t h e hypoglycemia p e r s i s t e d and was m a r g i n a l l y c o n t r o l l e d w i t h t h e same drugs. At 4 months of age, t h e p a t i e n t presented with a severe b i v e n t r i c u l a r hypertrophic cardiomyopathy and marked congestive f a i l u r e (RV end d i a s t o l i c p r e s s u r e = 18; L V end d i a s t o l i c = 23 mHg; Septal wall t h i c k n e s s = 8 mm, LV f r e e wall = 1 2 m ) Based upon t h e hypothesis t h a t hyperinsulinism might be an e t i o l o g y and t h e r e f r a c t o r i n e s s t o standard a n t i c o n g e s t i v e therapy, t h e remaining pancreas was removed. One year l a t e r t h e r e has been n e a r l y complete r e s o l u t i o n of t h e cardiomyopathy (RV end d i a s t o l i c p r e s s u r e = 5, L V end d i a s t o l i c = 12mHg; Septal thickness = 5mm, L V f r e e w a l l = 7 m ) . The c h i l d i s normoglycemic without medication. This patient's c l i n i c a l course suggests a r o l e f o r i n s u l i n i n c a r d i a c growthlhypertrophy. We recommend t h a t i n f a n t s with hyperinsulinism undergo a c a r d i a c e v a l u a t i o n . with IDD d u r a t i o n 7.9h3.7 yrs. without c l i n i c a l evidence of autonomic neuropathy.
An intravenous i n s u l i n bolus of 0.15-0.75 ulkg according t o hasal plasma glucose (PC) was given before and again a f t e r 3 days of i n t e n s i v e i n s u l i n therapy ([IT) .
Oral q u e s t i o n n a i r e s regarding hypoglycemic symptoms were completed a t each time blood samples were taken f o r measurements of P G and CATS. A hypoglycemic awareness s c o r e (HAS) was assigned t o each p a t i e n t .
A l l hut one p a t i e n t reported symptoms d u r i n g each t e s t . These occurred p r i o r t o hypoglycemia (PG>65 mg%) i n 73% before and 52X a f t e r IIT. The i n i t i a l symptoms ( u s u a l l y hunger) appeared a t 38i26 min. before and 35i18 min. a f t e r I I T a f t e r PC decrements of 121f81 (47f2XX) and 88f64 mg% (46*26%) resp. (NS). The CAT increments a t t h i s time were very small (1741.55, range 0-802 and 70f89, 0-262 pglml resp.).
The maximum HAS c o r r e l a t e d n e g a t i v e l y w i t h PG n a d i r , before (r=-.69, p<.001) but not a f t e r IIT.
The max HAS c o r r e l a t e d w i t h peak CAT response before (r=.42, p<.05) and a f t e r (r=0.42, p<.05) IIT.
In p a t i e n t s with PG n a d i r <65 mg%, t h e r e were no d i f f e r e n c e s i n HAS o r glucose recovery before and a f t e r TIT d e s p i t e t h e f a c t t h a t CAT response was s i g n i f i c a n t l y lower a f t e r I I T with some p a t i e n t s never achieving an increment >250 pglml. Thus hypoglycemic unawareness i s not common i n c h i l d r e n with ID0 and symptoms occur p r i o r t o the onset of hypoglycemia with minimal i f any CAT increments.
A SINGLE DOSE OF PANTOTHENATE, CYSTEINE, AND CARNITINE INCREASES LIVER COENZYME A AND ACETYL CoA LEVELS I N NORMAL INFANT MICE AND SUBSTANTIALLY l 10 3 REVERSES VALPROATE-INDUCED HEPATIC DYSFUNCTIC?I: POSSIBLE CLINICAL SIGNIFICANCE. J e a n Holowsch Thurston, Richard E. Hauhart, Washington U. Medical Center, Children's Hospital, Dept. of P e d i a t r . , St. Louis, MO. W e have previously reported t h a t v a l p r o a t e (VAL) reduced coenzymeA (CoA) and a c e t y l CoA (ACCOA) l e v e l s i n t h e Livers (LV) of 4-8-d-old mice.
In t h i s study, we attempted t o i n c r e a s e L V CoA and AcCoA s y n t h e s i s i n normal mice by s.c. i n j e c t i o n of pantothenate (~5 , 2 mmollkg), L-cysteine (CYST, 1 mmol/kg) and L-carnitine (CARN, 2.5 mmol/kg).
E f f e c t s i n VAL-t r e a t e d mice were a l s o examined. B5 + CYST + CARN had a s i g n i f i c a n t e f f e c t Measurement Control (N=4) B5+CYST+CARN (N=7) Change P CoA, #mollkg
